Showing results (141-150 of 376) with videos related to
Sort By:
Pageof 38
AIDS (London, England)|August 16, 2013
Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkersÁlvaro H Borges, Michael J Silverberg, Deborah Wentworth, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|June 9, 2006
Regional changes over time in initial virologic response rates to combination antiretroviral therapy across EuropeWendy P Bannister, Ole Kirk, Jose M Gatell, et al.AIDS (London, England)|September 22, 2007
The ability of four genotypic interpretation systems to predict virological response to ritonavir-boosted protease inhibitorsZoe V Fox, Anna Maria Geretti, Jesper Kjaer, et al.AIDS Care|October 19, 2022
The relationship between substance use and physical activity among people living with HIV, chronic pain, and symptoms of depression: a cross-sectional analysisEmily M Cherenack, Michael D Stein, Ana M Abrantes, et al.Surgical Infections|April 18, 2007
Inguinal lymph node biopsy in patients infected with the human immunodeficiency virus is safeDavid E Skarda, Jodie H Taylor, Jeffrey G Chipman, et al.AIDS (London, England)|January 16, 2008
Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDAWendy P Bannister, Lidia Ruiz, Alessandro Cozzi-Lepri, et al.AIDS (London, England)|January 10, 2015
Thrombocytopenia is associated with an increased risk of cancer during treated HIV diseaseÁlvaro H Borges, Jens D Lundgren, Annalisa Ridolfo, et al.AIDS (London, England)|August 28, 2007
Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-scoreAmanda Mocroft, Bruno Ledergerber, Kai Zilmer, et al.AIDS (London, England)|April 7, 2007
Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimenAlessandro Cozzi-Lepri, Andrew N Phillips, Lidia Ruiz, et al.The Journal of Infectious Diseases|July 17, 2009
Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settingsAlessandro Cozzi-Lepri, Andrew N Phillips, Javier Martinez-Picado, et al.Pageof 38